Next-generation sequencing may identify gene variations connected to psychosis metabolic process error


April 12, 2021 2 minutes read ADD SUBJECT TO

EMAIL INFORMS Get an e-mail when brand-new short articles are published on Please supply your e-mail address to get an e-mail when new posts

are posted on. Subscribe

CONTRIBUTED TO EMAIL SIGNALS We were not able to process your request. Please attempt again later on. If you continue to have this problem please contact Back to Healio

Next-generation sequencing might help identify gene variants linked to inborn errors of metabolic process among a subgroup of clients with psychosis, according to study outcomes published in Journal of Psychiatric Research.

“Due to the rarity of the individual [inborn mistakes of metabolism], just few psychiatrists understand psychotic symptoms due to underlying diseases as [inborn mistakes of metabolism],” Nikita van de Burgt, of the department of psychiatry and neuropsychology at Maastricht University’s School for Mental Health and Neuroscience in the Netherlands, and coworkers wrote. “For that reason, patients with psychotic symptoms due to [innate mistakes of metabolism] may be misdiagnosed and miss out on the chance to receive proper treatment.”

doctor with genetic strain Source: Adobe Stock According to the scientists, innate errors of metabolism can manifest later in life and are frequently identified by neuropsychiatric issues, such as psychosis. In the current study, van de Burgt and coworkers sought to assess the potential efficiency of screening patients who provided with a psychotic condition for inborn mistakes of metabolism with a single blood sample analyzed via next-generation sequencing (NGS), to identify unusual and treatable reasons for psychotic disorders. They obtained blood samples from 60 clients who had a psychotic disorder and a period of disease of less than 5 years and evaluated samples for 67 genes utilizing the Illumina MiSeq NGS technique. They then compared findings of the sequencing to the human referral genome and categorized variants according to the American College of Medical Genetics and Genomics classification.

Outcomes revealed 6 variants of class 4 (likely pathogenic) and class 5 (pathogenic) origin, all of which were heterozygous, which implied no patients appeared affected by an innate error of metabolic process. The scientists thought about the individuals of the control group as providers just and no individuals exhibited an inborn mistake of metabolism as an underlying disease according to this technique. However, van de Burgt and associates noted the possible effectiveness of NGS for discovering gene versions linked to innate mistakes of metabolism amongst an enriched subgroup of patients with psychosis.

“As screening for [inborn mistakes of metabolism] still needs invasive and time- consuming techniques, this research study showed that a NGS approach is a great, reasonably inexpensive, alternative to utilizing numerous blood samples, urine samples, cerebrospinal fluid and MRI scans to discover hetero- or homo-zygous variants of genes connected to [innate errors of metabolism],” the scientists wrote. “Consequently, the detection of [inborn errors of metabolic process] may be limited to using only one blood sample in the future. Taken together, future research ought to focus on screening for hereditary variants connected with [inborn errors of metabolic process] in ‘enriched, high-risk’ clients with the use of NGS.”


Get an e-mail when new articles are published on

Please supply your email address to get an e-mail when new short articles are published on.


We were unable to process your demand. Please attempt once again later. If you continue to have this concern please contact